Sernova Biotherapeutics Inc (FRA:PSH0)

Germany flag Germany · Delayed Price · Currency is EUR
0.1220
+0.0100 (8.93%)
At close: Sep 26, 2025
8.93%
Market Cap37.25M
Revenue (ttm)n/a
Net Income (ttm)-11.69M
Shares Outn/a
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume922
Average Volume3,206
Open0.1200
Previous Close0.1120
Day's Range0.1040 - 0.1390
52-Week Range0.0805 - 0.1841
Betan/a
RSI51.00
Earnings DateSep 12, 2025

About Sernova Biotherapeutics

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is headquartered... [Read more]

Industry Biological Products, Except Diagnostic Substances
CEO Jonathan M. Rigby
Employees 17
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol PSH0
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.